A Northwestern Medicine study has identified a previously unrecognized population of immune cells that appears to fuel harmful blood vessel growth in multiple blinding eye diseases, according to the study published in the Journal of Clinical Investigation. The discovery could open the door to new treatments for patients who don't respond to existing therapies, said the study's senior author Jeremy Lavine, M.D., Ph.D., assistant professor of ophthalmology.
❓ Unknown
New Immune Cells Linked to Harmful Blood Vessel Growth in Eye Diseases
Just now
October 26, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A study by Northwestern Medicine has discovered a new type of immune cell that contributes to harmful blood vessel growth in blinding eye diseases, potentially leading to new treatments for patients unresponsive to current therapies. This research, led by Dr. Jeremy Lavine, could have implications for healthcare advancements in Iran. Improved treatments for eye diseases may enhance the quality of life for patients in Iran.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Three Executed in Isfahan: A Woman for Murder and Two Men for Drug Offenses
8 min ago •
Creating Integrated Conservation Landscapes: A Key to Strengthening Conservation Efforts
8 min ago •
Victorian Spiritualism: A Commercial Response to the Desire for Afterlife Communication
9 min ago •
Fructose May Suppress Liver Tumors in Mice, Offering New Treatment Insights
12 min ago •